| EPD265 | Perspectives on perceived barriers and benefits of integration of harm reduction services and PrEP among people who use drugs in Uganda | E-poster | Harm reduction |
| EPF135 | Perspectives on research participation from pregnant women living with HIV | E-poster | Ethical aspects and standards in research (including clinical trials) |
| EPD555 | Pervasive COVID-19 pandemic impacts on access to HIV prevention and sexual and reproductive health services, mental health and substance use among racialized sexual and gender minority people in Toronto (#SafeHandsSafeHearts) | E-poster | Effects of the COVID-19 on key populations |
| PESAB09 | Pharmacokinetic and 48 week efficacy of once-daily vs twice-daily dolutegravir among patients with human immunodeficiency virus/tuberculosis coinfection receiving rifampicin based tuberculosis therapy: a randomized control trial | Poster exhibition | Tuberculosis: Prevention, diagnosis, treatment |
| EPB175 | Pharmacokinetic modeling and simulation of intramuscular and subcutaneous ibalizumab delivery | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| EPB176 | Pharmacokinetics (PK) and tolerability of cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) intramuscular (IM) injections to the vastus lateralis (lateral thigh) muscles of healthy adult participants | E-poster | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| PESUB22 | Pharmacokinetics of a simplified subcutaneous lenacapavir regimen versus Phase 2/3 regimen | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring |
| PEMOA28 | Pharmacologic intervention to reduce chronic inflammation in people with HIV | Poster exhibition | Immunotherapy (including broadly neutralizing antibodies) |
| OAA0102 | Pharmacological enhancement of IL-15 signaling to improve 'shock-and-kill' strategies against latent HIV | Oral abstract session with live Q&A | Strategies to reduce/eliminate viral reservoirs |
| EPB129 | Pharmacotherapeutic profile, polypharmacy and its associated factors in a cohort of people living with HIV in Rio de Janeiro, Brazil | E-poster | Polypharmacy |